Boston Scientific Corp. acquired privately held Obisidio Inc., adding the company’s gel embolic material (GEM) technology to its portfolio. GEM is a ready-to-use, semi-solid material that conforms to the vasculature in which it is placed to immediately obstruct or reduce blood flow to a tumor or abnormality or stop hemorrhaging. Read More
Moximed Inc. has received $40 million in series C financing to pursue regulatory approval for its implantable shock absorber (ISA) for knee osteoarthritis (OA). Fremont, Calif.-based Moximed secured backing from investors including Advent Life Sciences, New Enterprise Associates, Future Fund, Vertex Healthcare and Runway Growth Capital to advance the Misha knee system. The company is touting the technology as the world’s first implantable shock absorber for OA. Read More
Becton Dickinson & Co. and Laboratory Corp. of America Holdings (Labcorp)are teaming up to develop, market and commercialize flow cytometry-based companion diagnostics (CDx) for cancer and other diseases. The agreement also paves the way for BD and Labcorp to collaborate with pharmaceutical partners. Read More
The doctrine of patent assignor estoppel is not found in the U.S. statute, but that omission has led to only limited litigation over the doctrine despite the notoriety of the case of Hologic v. Minerva. Nonetheless, the Federal Circuit reinforced the understanding that an assigned patent is still in force when the disputed claim is not seen has having been materially broadened by the time a patent has been granted in its final form, thus closing one of the principal contractual questions surrounding patents that are handed off from one device maker to another. Read More
Gleamer SAS is joining forces with Fujifilm Europe GmbH to integrate its Boneview AI software into Fujifilm X-ray systems. Gleamer's advanced algorithm platform detects and localizes lesions on radiographs, graphically highlighting areas of interest, before submitting the images to radiologists for validation. Read More
Beijing Longwood Valley Medical Technology Co. Ltd. (also known as Changmugu Medical) recently completed a series B financing of ¥540 million ($79.7 million) to advance its artificial intelligence (AI) medical products. It also signed a strategic partnership with Johnson & Johnson Medical China Ltd. Read More
Regardless of the grading scale, the U.S. NIH would have gotten an “F” for its failure to ensure that intramural and extramural clinical trials it funded complied with government reporting requirements in 2019 and 2020. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Imaging Endpoints, Perkinelmer, Philips, Sema4, Versea, WCG. Read More
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Beyond Air, Genetikaplus, Gerresheimer, Improvita, Invivoscribe, Kronos, Zollner. Read More
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cytosorbents, Edwards Lifesciences, Thermofisher, Visibly. Read More
